Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
De Menge AB
AB
Active
Org 5593187908
Västra Frölunda
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2021 · 5 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
De Menge AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
0M
-1M
-1M
2021: 0M
0M
2021
2022: 0M
0M
2022
2024: 0M
0M
2024
EBITDA
SEK millions
0M
-3M
-6M
-8M
-11M
2021: 0M
0M
2021
2022: 0M
0M
2022
2024: -9M
-9M
2024
Income statement
SEK thousands
Item
2024
2022
2021
Revenue
0
0
0
Staff expenses
−0
−0
—
EBITDA
−8 939
−8
0
Depreciation & amort.
−0
—
−0
EBIT
−8 939
−8
0
Net financials
0
—
—
Profit before tax
−8 939
−8
0
Tax
−0
—
−0
Net profit
−8 939
−8
0
Balance sheet
SEK thousands
Item
2024
2022
2021
Total assets
12 410
20 303
15 863
Equity
−2 062
6 817
6 825
Long-term debt
10 973
9 986
9 038
Short-term debt
3 500
3 500
0
Total debt
14 473
13 486
9 038
Financial ratios
5-year trend
EBITDA margin
<−999 %
This company
15,8 %
Market median
This company
Market median
>999% below market
2021
2024
Equity ratio
−16,6 %
This company
38,2 %
Market median
This company
Market median
143% below market
2021
2024
Return on equity
—
This company
18,4 %
Market median
This company
Market median
2021
2024
Net profit margin
<−999 %
This company
8,1 %
Market median
This company
Market median
>999% below market
2021
2024
Asset turnover
0,00×
This company
1,12×
Market median
This company
Market median
100% below market
2021
2024
Debt / equity
—
This company
0,62×
Market median
This company
Market median
2021
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-05-01 – 2021-12-31
View
PDF
More on De Menge AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
